Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Jessen

Showing results (11-20 of 534) with videos related to

Pageof 54
Sort By:
JAMA|September 16, 2015
Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease RiskMichael Wagner, Frank Jessen
Der Nervenarzt|September 24, 2025
[Dementia: changes from ICD-10 to ICD-11. German Version]Frank Jessen, Karl Broich
Der Nervenarzt|October 14, 2025
Dementia: changes from ICD-10 to ICD-11Frank Jessen, Karl Broich
Der Nervenarzt|March 2, 2026
[Introduction to the topic: analysis and optimization of the work of outpatient memory clinics]Frank Jessen, Lutz Frölich
The Lancet Regional Health. Europe|May 25, 2026
A Clinician View of the EMA Explanation of the Approval of Amyloid-Targeting TherapiesFrank Jessen, Juan Fortea
The Journal of Prevention of Alzheimer'S Disease|February 26, 2025
Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's diseaseJurij Rosen, Frank Jessen
Der Nervenarzt|August 24, 2019
[Prevention of cognitive decline and dementia by treatment of risk factors]Claus Escher, Frank Jessen
Der Nervenarzt|September 8, 2019
[Quo vadis Alzheimer?]Frank Jessen, Christian Haass
Fortschritte Der Neurologie-Psychiatrie|July 20, 2022
[Dementia: Current Status]Joachim Klosterkötter, Frank Jessen
Der Nervenarzt|April 18, 2020
[Early detection of Alzheimer's disease and dementia prediction in patients with mild cognitive impairment : Summary of current recommendations]Ayda Rostamzadeh, Frank Jessen
Pageof 54

Showing results (11-20 of 534) with videos related to

Sort By:
Pageof 54
JAMA|September 16, 2015
Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease RiskMichael Wagner, Frank Jessen
Der Nervenarzt|September 24, 2025
[Dementia: changes from ICD-10 to ICD-11. German Version]Frank Jessen, Karl Broich
Der Nervenarzt|October 14, 2025
Dementia: changes from ICD-10 to ICD-11Frank Jessen, Karl Broich
Der Nervenarzt|March 2, 2026
[Introduction to the topic: analysis and optimization of the work of outpatient memory clinics]Frank Jessen, Lutz Frölich
The Lancet Regional Health. Europe|May 25, 2026
A Clinician View of the EMA Explanation of the Approval of Amyloid-Targeting TherapiesFrank Jessen, Juan Fortea
The Journal of Prevention of Alzheimer'S Disease|February 26, 2025
Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's diseaseJurij Rosen, Frank Jessen
Der Nervenarzt|August 24, 2019
[Prevention of cognitive decline and dementia by treatment of risk factors]Claus Escher, Frank Jessen
Der Nervenarzt|September 8, 2019
[Quo vadis Alzheimer?]Frank Jessen, Christian Haass
Fortschritte Der Neurologie-Psychiatrie|July 20, 2022
[Dementia: Current Status]Joachim Klosterkötter, Frank Jessen
Der Nervenarzt|April 18, 2020
[Early detection of Alzheimer's disease and dementia prediction in patients with mild cognitive impairment : Summary of current recommendations]Ayda Rostamzadeh, Frank Jessen
Pageof 54